Skip to main content
Clinical Trials/NCT00506272
NCT00506272UnknownNot Applicable

Inpatient Self Monitoring and Administration Study (ISMAS)

Atlanta VA Medical Center1 site in 1 country1 target enrollmentStarted: December 1, 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
1
Locations
1
Primary Endpoint
number of blood glucose measurements obtained/number of blood glucose measurements ordered

Study Overview

Brief Summary

ISMAS is designed to test the hypothesis that self management of insulin dependent diabetes mellitus by selected patients admitted for elective surgery is more efficacious than standard care with respect to overall glycemic control, attaining finger-stick blood sugars, and administering insulin.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Male or female, age < 80
  • •Most recent hemoglobin A1C within the past 6 months < 12%
  • •Recent history of regular self-administered peripheral blood glucose checks as an outpatient
  • •Recent history of insulin self-administration at least twice a day as an outpatient
  • •Admitted for a hospitalization anticipated to last at least 3 days
  • •Mini Mental Status Examination (MMSE) ≥ 25 at admission and the same or better post-operatively
  • •All patients will be actively followed by the Endocrinology inpatient consultation team during the hospitalization.

Exclusion Criteria

  • •Currently receiving peritoneal or hemodialysis
  • •Patients with unstable angina
  • •History of myocardial infarction within 3 weeks prior to enrollment
  • •Current admission due to or associated with altered mental status or encephalopathy
  • •History of an episode of altered mental status or encephalopathy within the 4 weeks prior to enrollment
  • •A confirmed diagnosis of dementia
  • •Inability to self-adjust insulin
  • •No recent history of ability to perform regular peripheral blood glucose checks
  • •Frequency of hypoglycemia (< 60 mg/dL) > twice/week by history
  • •Inability to eat without assistance
  • •Study objectives will not be pursued in patients during stays in any intensive care unit.

Arms & Interventions

Standard care

Experimental

Patients admitted for elective surgery will receive standard diabetes care, including but not limited to finger stick blood glucose determinations, and insulin injections delivered by the nursing staff.

Intervention: Standard care (Procedure)

Patient administered care

Experimental

Patients will self-monitor and record finger-stick blood glucose measurements, and self administer insulin at doses agreed upon with the consulting endocrinology in-patient service.

Intervention: Self blood glucose monitoring and insulin administration (Procedure)

Outcomes

Primary Outcomes

number of blood glucose measurements obtained/number of blood glucose measurements ordered

Time Frame: patients will be followed for the duration of hospital stay, an expected average of 5 days

number of insulin doses administered/number of insulin doses prescribed

Time Frame: patients will be followed for the duration of hospital stay, an expected average of 5 days

average blood glucose

Time Frame: patients will be followed for the duration of hospital stay, an expected average of 5 days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Fed
Responsible Party
Principal Investigator
Principal Investigator

Peter Thule

Chief, Section Endocrinology

Atlanta VA Medical Center

Study Sites (1)

Loading locations...

Similar Trials